[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
February 26, 1982

Management of Ventricular Tachyarrhythmias: Part II

Author Affiliations

From the Natalie and Norman Soref and Family Electrophysiology Laboratory, University of Wisconsin-Mount Sinai Medical Center, Milwaukee.

JAMA. 1982;247(8):1178-1181. doi:10.1001/jama.1982.03320330074035

IN A previous issue of The Journal (1982;247:671-674), the role of drug therapy in the control of ventricular tachyarrhythmias was explored. The discussion of this therapeutic approach continues, and two other broad categories of management, "pacing" and "surgery," are examined.

Drug Therapy 

Role of Electrophysiological Studies and Serial Drug Testing.—  In recent years, electrophysiological studies have been used in an attempt to achieve a more objective therapeutic end point for the control of ventricular tachyarrhythmias.1 This has been made possible by the realization that ventricular tachyarrhythmias can be induced by programmed electrical stimulation (PES) in the controlled environments of the electrophysiology laboratory. This is particularly true of ventricular tachycardia (VT) and ventricular fibrillation (VF), both of which are generally reentrant in nature and, therefore, inducible with PES in a majority of patients who have experienced VT or VF or both. Programmed electrical stimulation is accomplished through electrode catheters (similar